85 FR 182 pgs. 58390-58391 - Bulk Manufacturer of Controlled Substances Application: Rhodes Technologies
Type: NOTICEVolume: 85Number: 182Pages: 58390 - 58391
Pages: 58390, 58391Docket number: [Docket No. DEAβ719]
FR document: [FR Doc. 2020β20596 Filed 9β17β20; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-719]
Bulk Manufacturer of Controlled Substances Application: Rhodes Technologies
AGENCY:
Drug Enforcement Administration, Justice.
ACTION:
Notice of application.
SUMMARY:
Rhodes Technologies has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information.
DATES:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before November 17, 2020. Such persons may also file a written request for a hearing on the application on or before November 17, 2020.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.33(a), this is notice that on February 13, 2020, Rhodes Technologies, 498 Washington Street, Coventry, Rhode Island 02816, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s):
Controlled substance | Drug code | Schedule |
---|---|---|
Marihuana | 7360 | I |
Tetrahydrocannabinols | 7370 | I |
Dihydromorphine | 9145 | I |
Methylphenidate | 1724 | II |
Codeine | 9050 | II |
Dihydrocodeine | 9120 | II |
Oxycodone | 9143 | II |
Hydromorphone | 9150 | II |
Hydrocodone | 9193 | II |
Levorphanol | 9220 | II |
Morphine | 9300 | II |
Oripavine | 9330 | II |
Thebaine | 9333 | II |
Oxymorphone | 9652 | II |
Noroxymorphone | 9668 | II |
Tapentadol | 9780 | II |
Fentanyl | 9801 | II |
[top] The company plans to manufacture the above-listed controlled substance(s) in bulk for conversion and sale to finished dosage form manufacturers. In
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-20596 Filed 9-17-20; 8:45 am]
BILLING CODE P